XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection

Veure altres versions (1)

As the options for systemic treatment of malignant melanoma (MM) increase, the need to develop biomarkers to identify patients who might benefit from cytotoxic chemotherapy becomes more apparent. In preclinical models, oxaliplatin has activity in cisplatin-resistant cells. In this study, we have sho...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hatch, S, Swift, L, Caporali, S, Carter, R, Hill, E, Macgregor, T, D'Atri, S, Middleton, M, McHugh, P, Sharma, R
Format:	Journal article
Publicat:	2014

Ítems similars

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
per: Hatch, S, et al.
Publicat: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
per: MacGregor, T, et al.
Publicat: (2018)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
per: T. P. MacGregor, et al.
Publicat: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
per: Sharma, R, et al.
Publicat: (2012)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
per: Gillies, R, et al.
Publicat: (2011)

XPF-ERCC1: Linchpin of DNA crosslink repair
per: McHugh, PJ
Publicat: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
per: Peter J McHugh
Publicat: (2020-04-01)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
per: Yang, J, et al.
Publicat: (2010)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
per: Graf, Nora, et al.
Publicat: (2012)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
per: Ming-Yii Huang, et al.
Publicat: (2023-05-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
per: Bhagwat, N, et al.
Publicat: (2009)

RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
per: Abdullah, U, et al.
Publicat: (2017)

RPA activates the XPF‐ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks
per: Abdullah, U, et al.
Publicat: (2017)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
per: Jiajia Wang, et al.
Publicat: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
per: Wang, A, et al.
Publicat: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
per: Wang, A, et al.
Publicat: (2011)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
per: Matheus Treuk Medeiros de Araújo
Publicat: (2024-05-01)

Progressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
per: Ruben D. Ramirez, et al.
Publicat: (1999-04-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
per: Thomas, A, et al.
Publicat: (2019)

Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?
per: Hill, E, et al.
Publicat: (2012)

Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?
per: Hill, E, et al.
Publicat: (2012)

Xpf suppresses the mutagenic consequences of phagocytosis in Dictyostelium
per: Pontel, LB, et al.
Publicat: (2016)

Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine
per: Joseph W. George, et al.
Publicat: (2019-01-01)

XPF activates break-induced telomere synthesis
per: Chia-Yu Guh, et al.
Publicat: (2022-10-01)

Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
per: Galliardt Melanie, et al.
Publicat: (2023-05-01)

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
per: Diana Groza, et al.
Publicat: (2018-05-01)

Association of ERCC1 and XPF polymorphisms with pediatric glioma susceptibility
per: Yongping Chen, et al.
Publicat: (2023-03-01)

Function and Interactions of ERCC1-XPF in DNA Damage Response
per: Maryam Faridounnia, et al.
Publicat: (2018-12-01)

XPF expression and its relationship with the risk and prognosis of colorectal cancer
per: Huixin Hu, et al.
Publicat: (2021-01-01)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
per: Qing-nan Zhou, et al.
Publicat: (2023-05-01)

Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
per: Ji Hoon Choi, et al.
Publicat: (2014-01-01)

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
per: An Na Seo, et al.
Publicat: (2014-03-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
per: Mariangela Sabatella, et al.
Publicat: (2021-01-01)

Association between XPF polymorphisms and cancer risk: a meta-analysis.
per: Ting-Yan Shi, et al.
Publicat: (2012-01-01)

A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
per: Ezanno Anne-Cecile, et al.
Publicat: (2022-01-01)

Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor Chemotherapy
per: Armando Cevenini, et al.
Publicat: (2020-06-01)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
per: Zhao Y, et al.
Publicat: (2021-01-01)

XPF-673C>T polymorphism effect on the susceptibility to esophageal cancer in Chinese population.
per: Yingwen Liu, et al.
Publicat: (2014-01-01)

Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma
per: Farhan Ashraf, et al.
Publicat: (2016-01-01)

The Social Service between Values and Welfare Policies (Il Servizio Sociale tra Valori e Politiche di Welfare)
per: Francesca D'Atri
Publicat: (2017-07-01)